SK Bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
SK bioscience has launched an Artificial Intelligence (AI)-powered initiative to improve vaccine development decisions, supporting next-generation injectable rotavirus vaccines and expanding access in Low- and Middle-Income Countries (LMICs).
Rotavirus Vaccine | 04/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy